Clinical Trials Logo

Central Sleep Apnea clinical trials

View clinical trials related to Central Sleep Apnea.

Filter by:

NCT ID: NCT06313840 Recruiting - Heart Failure Clinical Trials

Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction

COG01
Start date: August 21, 2023
Phase:
Study type: Observational

Study to assess the prevalence of central sleep apnea in patients with heart failure with reduced or mildly reduced left ventricular ejection fraction (LVEF <50%) followed by case-control study to assess the link between central sleep apnea and cognitive function

NCT ID: NCT06043830 Recruiting - Chronic Pain Clinical Trials

Managing Opioid Related Sleep Apnea With Acetazolamide

MORPHO
Start date: October 18, 2023
Phase: Phase 2
Study type: Interventional

Patients with chronic pain who use opioids appear to be at increased risk for breathing issues during sleep, termed sleep disordered breathing (SDB). Treatment of SDB often consists of use of a device during sleep that provides continuous positive airway pressure (CPAP) via a mask interface. However, this device is not effective or tolerated in all individuals. The goal of this study is to examine whether a medication called acetazolamide can improve SDB, as an alternative to CPAP treatment. The investigators will measure the improvement in SDB, as well as any change in symptoms, during a 1 week treatment with acetazolamide compared with 1 week of placebo (sugar pill). This study will help to provide data for longer term studies of treatment for SDB in patients who use opioids.

NCT ID: NCT05949164 Recruiting - Clinical trials for Obstructive Sleep Apnea

The IPAd Study: Exploring the Association Between Insomnia and Positive Airway Pressure Adherence in Children

IPAd
Start date: May 16, 2023
Phase:
Study type: Observational

Sleep-disordered breathing (SDB) is prevalent in children and adolescents and untreated SDB impacts key indicators of physical and psychosocial health. Positive airway pressure (PAP) therapy is highly effective for the treatment of SDB and is associated with favorable clinical outcomes but is limited by poor adherence. Emerging literature in adults suggests that intolerance to PAP therapy may be related to coexisting insomnia. However, the presence of insomnia in children with known SDB as well as its impact on PAP adherence have not been explored. This proposal will explore the association of coexisting insomnia on PAP adherence in children with SDB using a cross-sectional study design. The investigators will assess the association between insomnia and PAP therapy adherence, measured as the mean minutes of nightly PAP usage over 6 months of use on objective downloads.

NCT ID: NCT05354401 Completed - Obesity Clinical Trials

Heated Humidified High Flow Nasal Cannula Oxygen in Obstructive Sleep Apnea in Adolescents

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The research study is being done to test heated humidified high-flow air (HHF), as a treatment for OSA.

NCT ID: NCT04907058 Completed - Central Sleep Apnea Clinical Trials

Central Sleep Apnea Treated by CO2 Supplied by a Novel Device

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

In general, central sleep apnea is not as common as obstructive sleep apnea but it is common in patients with heart failure. It has been repeatedly shown that central sleep apnea worsens the prognosis of heart failure. The current concept in the development of CSA is hypocapnia which causes temporary cessation of respiratory neural output. Different methods for supplement of CO2 have been used to eliminate CSA. However, variation of CO2 concentration during overnight treatment and tight-fitting mask made the treatment uncomfortable. It is important to develop a device with a comfortable mask to supply constant low dose CO2 without breathing difficulty. We recently developed a device for treatment of CSA.

NCT ID: NCT03919344 Terminated - Central Sleep Apnea Clinical Trials

Pathophysiological Study of CSA in Adults With pLVEF

PHENOSAX
Start date: February 2, 2021
Phase: N/A
Study type: Interventional

Sleep apnea is classically divided into obstructive and central apnea, according to the persistence or otherwise of respiratory movements and the existence or not of pharyngeal collapse during apnea. However, there is evidence to suggest that some mechanisms are common to both types of apnea. Although the pathophysiology of obstructive apnea has been the subject of much work and now seems fairly well known, there is much less data on central apnea. These apneas can occur in different comorbid contexts. They are more frequently present in patients with heart failure, regardless of the etiology, and are associated with an adverse prognosis. The investigators hypothesize that the physiopathology of adult central apnea syndrome involves, in addition to ventilatory control abnormalities, upper airway abnormalities (VAS). The objective is to study the pathophysiology of central SAS, by first comparing the collapse of VAS of central apneic patients to those of patients with simple snoring or obstructive sleep apnea. In a second step, the investigators will analyze the cardiorespiratory coupling and will establish a map of the respiratory neural network in patients with central apnea. The investigators will focus their study on patients with central SAS (with preserved systolic heart function) due to the epidemiology of SAS.

NCT ID: NCT03884660 Recruiting - Central Sleep Apnea Clinical Trials

remedē System Therapy Study

reST
Start date: June 18, 2019
Phase:
Study type: Observational

The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.

NCT ID: NCT03745898 Terminated - Heart Failure Clinical Trials

The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea

Start date: April 15, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to evaluate the long-term effects of Nocturnal Oxygen Therapy (NOXT) on the mortality and morbidity of patients with stable heart failure and a reduced ejection fraction (HFrEF), already receiving optimal guideline-directed medical therapy (GDMT), who have central sleep apnea (CSA).

NCT ID: NCT03670914 Suspended - Central Sleep Apnea Clinical Trials

Diagnosis of Sleep-Related Respiratory Disorders in Patients With Narcotic Medications

WP-NARC001
Start date: August 8, 2019
Phase: N/A
Study type: Interventional

The present study is a prospective, single cohort study involving patients on narcotic medications, undergoing overnight sleep studies in the clinical sleep laboratory. The main hypothesis for the study is that the the frequency of sleep respiratory events (including central apneas) identified by a home sleep apnea test (HSAT) device (WatchPAT200U (wp200U) with centrals; Itamar Medical Ltd.) will significantly correlate with in-lab polysomnography (gold standard).

NCT ID: NCT03621566 Recruiting - Central Sleep Apnea Clinical Trials

Belgian Central Sleep Apnea REgistry

B-CARE
Start date: June 25, 2018
Phase:
Study type: Observational [Patient Registry]

This study evaluates different factors that determine the treatment choice and treatment compliance in patients with central sleep apnea. All patients will receive routine care (registry).